This could indicate a higher representation of the canonical (E26 transformation-specific transcription factor 6) ETV6-NTRK3 fusion in several cancer types but could also reflect testing platforms and referral bias affecting the cancer distribution for each study. Here, NTRK3 is linked to cancer.